Sam Donaldson Named Inaugural Chair of NCCN Foundation BoardThe NCCN 15th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care commenced on Wednesday, March 10, 2010, with an announcement that veteran ABC news anchor Sam Donaldson has been named as chair of the newly established NCCN Foundation Board of Directors.William T. McGivney, PhD, Chief Executive Officer of NCCN, noted, “We are thrilled that Mr. Donaldson has accepted the position as chair of the NCCN Foundation Board of Directors. I am confident that he will provide wise and practical leadership as we look to implement programs that will benefit patients with cancer as well as researchers.”The NCCN Foundation was recently established as the philanthropic affiliate of the NCCN to embrace the NCCN mission of improving the quality and effectiveness of care provided to patients with cancer, while providing additional information and resources for informed decision-making.“As a champion of the NCCN and of the amazing work they do, I am honored to serve on the NCCN Foundation Board of Directors and look forward to lending my voice to contribute to its many significant accomplishments,” said Sam Donaldson.“As one of the 12 million cancer survivors in the United States today, I can personally attest to the need for credible information that patients can use to help them navigate the overwhelming and emotional task of deciding on treatment,” he noted.The NCCN Foundation will also seek philanthropic support for effective distribution of the NCCN Patient Guidelines, as well as...
Sam Donaldson Named Inaugural Chair of NCCN Foundation Board

The NCCN 15th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care commenced on Wednesday, March 10, 2010, with an announcement that veteran ABC news anchor Sam Donaldson has been named as chair of the newly established NCCN Foundation Board of Directors.

William T. McGivney, PhD, Chief Executive Officer of NCCN, noted, “We are thrilled that Mr. Donaldson has accepted the position as chair of the NCCN Foundation Board of Directors. I am confident that he will provide wise and practical leadership as we look to implement programs that will benefit patients with cancer as well as researchers.”

The NCCN Foundation was recently established as the philanthropic affiliate of the NCCN to embrace the NCCN mission of improving the quality and effectiveness of care provided to patients with cancer, while providing additional information and resources for informed decision-making.

“As a champion of the NCCN and of the amazing work they do, I am honored to serve on the NCCN Foundation Board of Directors and look forward to lending my voice to contribute to its many significant accomplishments,” said Sam Donaldson.

“As one of the 12 million cancer survivors in the United States today, I can personally attest to the need for credible information that patients can use to help them navigate the overwhelming and emotional task of deciding on treatment,” he noted.

The NCCN Foundation will also seek philanthropic support for effective distribution of the NCCN Patient Guidelines, as well as the translation of these guidelines into multiple foreign languages. It will also be looking to attain funds to develop and distribute NCCN Cancer Medication Information Sheets (NCCN CMI), a resource to assist patients with safety and compliance concerns related to complex medication regimens, as well as developing survivorship programs for the growing population of cancer survivors.

Since research is a critical component to the ongoing advancement of cancer treatments, an additional focus of the NCCN Foundation is to develop programs to encourage and assist “Young Investigators” as well as nurses in conducting innovative and collaborative research in clinical oncology at NCCN Member Institutions.

NCCN Guidelines Expand Their Reach to Japan

The NCCN Clinical Practice Guidelines in Oncology have been further recognized as the global standard in oncology with the announcement that select NCCN Guidelines are being translated into Japanese. The Translational Research Informatics Center (TRI) Foundation for Biomedical Research and Innovation, under the supervision of the Japanese Society for Cancer of the Colon and Rectum, has translated the NCCN Guidelines for Colon Cancer and Rectal Cancer, which are now available online. In addition, Japanese translations of the NCCN Guidelines for Anal Carcinoma and Colorectal Cancer Screening will be published shortly, and additional Japanese translations of the NCCN Guidelines in urological cancers will be developed throughout the coming year.

“NCCN is pleased to be able to collaborate with clinicians in Japan in determining appropriate and effective avenues of care for their oncology patients,” said William T. McGivney, PhD, Chief Executive Officer, NCCN. “As the arbiter of high-quality cancer care, NCCN remains dedicated to enhancing our international relationships to improve the quality, effectiveness, and efficiency of oncology practice so patients worldwide can live better lives.”

“In Japan, more than 500,000 people are diagnosed with cancer each year and more than 335,000 die from the disease every year,” said Masanori Fukushima, MD, PhD, Professor Emeritus, Kyoto University, Director and Chairman of TRI. “Consequently, by aligning with NCCN to provide our clinicians with treatment recommendations developed by world-renowned experts in cancer, we look to improve the care provided to patients and impact the number of cancer survivors in Japan.”

If the inline PDF is not rendering correctly, you can download the PDF file here.

Article Sections

Article Information

PubMed


Google Scholar

Related Articles

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 8 8 1
PDF Downloads 1 1 1
EPUB Downloads 0 0 0